Mohrag Mostafa, Mojiri Mohammed E, Hakami Manar S, Alghamdi Mohammed S, Moafa Abdulaziz Y, Kreet Sawsan J, Alghamdi Saad M, Nasib Hams A, Alghamdi Omar R, Ayoub Saleha M, Hakami Aesha A, Tawashi Sarah M, Tayeb Rola M, Kariry Azezh A, Ayyashi Salem M
Department of Medicine, Jazan University, Jazan, SAU.
College of Medicine, Jazan University, Jazan, SAU.
Cureus. 2024 Oct 10;16(10):e71220. doi: 10.7759/cureus.71220. eCollection 2024 Oct.
Hypertension is a major global health concern and a leading risk factor for cardiovascular disease and premature death. Despite effective treatments, blood pressure control remains suboptimal due to challenges in medication adherence, lifestyle modifications, and regular monitoring. Wearable technologies offer potential solutions by providing continuous monitoring and promoting healthier behaviors. This systematic review and meta-analysis evaluated the impact of wearable technologies on blood pressure control in hypertensive patients. A comprehensive search of databases identified six randomized controlled trials, which varied in sample size, interventions, and outcomes. The meta-analysis revealed small, non-significant effects on systolic (standardized mean difference (SMD) = -0.27, 95%CI -0.57, 0.04) and diastolic (SMD = -0.16, 95%CI -0.41, 0.08) blood pressure, with considerable heterogeneity across studies. While wearable technologies show promise in hypertension management, their effects on blood pressure control are inconsistent. Future research should focus on more tailored interventions, identifying patient subgroups that may benefit most, and integrating wearables with traditional care to enhance hypertension management.
高血压是全球主要的健康问题，也是心血管疾病和过早死亡的主要危险因素。尽管有有效的治疗方法，但由于药物依从性、生活方式改变和定期监测方面的挑战，血压控制仍未达到最佳状态。可穿戴技术通过提供持续监测和促进更健康的行为提供了潜在的解决方案。这项系统评价和荟萃分析评估了可穿戴技术对高血压患者血压控制的影响。对数据库进行全面检索后确定了六项随机对照试验，这些试验在样本量、干预措施和结果方面各不相同。荟萃分析显示，对收缩压（标准化均值差（SMD）=-0.27，95%置信区间-0.57，0.04）和舒张压（SMD=-0.16，95%置信区间-0.41，0.08）的影响较小且无统计学意义，各研究之间存在相当大的异质性。虽然可穿戴技术在高血压管理方面显示出前景，但其对血压控制的影响并不一致。未来的研究应侧重于更具针对性的干预措施，确定可能最受益的患者亚组，并将可穿戴设备与传统护理相结合，以加强高血压管理。
